Introduction
The family Picornaviridae is large and diverse, with members producing disease in man, domestic animals and even insects. Picornavirus infections represent good examples of antibody-mediated immunity in protection and recovery from acute infections. T lymphocytemediated immunity is being studied increasingly, both from the viewpoint of providing immunological help for the B lymphocyte response and its role in the immunopathology seen in some chronic picornavirus infections. Impetus for the study of antigenic sites on these viruses has come from the desire to develop peptide-based vaccines, which would be both safer and more convenient than currently available attenuated virus preparations. Fig. 1 shows the relationship between different picornaviruses based on the nucleotide similarity in the P1 region. There is a considerable degree of sequence identity (usually > 50 %) in this region between different members of the same genus (Stanway, 1990) . The most variable regions of the capsid proteins often form parts of antigenic sites on the assembled virion. In recent years the antigenic sites have been mapped for a number of picornaviruses.
Antibody recognition sites on picornaviruses
The method of choice for the characterization of these sites was the generation and sequencing of monoclonal antibody-resistant variants. Such an approach was technically feasible due to the relatively small size of the picornavirus genome (7 8"5 kb) and the fact that many (although not all) picornaviruses can be grown easily in tissue culture. The studies by Sherry et at. (1986) on human rhinovirus-14 and Minor et al. (1986) on poliovirus typify this approach, which consisted of the following steps.
(1) A number of virus-specific monoclonal antibodies were generated, and each tested for their ability to neutralize virus infectivity.
(2) These antibodies were incubated with wild-type in tissue culture, resulting in the selection of monoclonal antibody-resistant variants.
(3) Each member of the panel of monoclonal antibodies was tested against each monoclonal antibodyresistant variant to test which antibodies were capable of neutralizing which variants. Where a monoclonal antibody was unable to neutralize a variant selected with a different antibody the two antibodies were considered to bind to the same antigenic site. If a large enough panel of antibodies and variants was used, clusters were identified allowing the number of antigenic sites to be calculated.
(4) Sequencing of the neutralization-resistant variants revealed that many had single point mutations in genes encoding capsid proteins. Thus, it could be concluded that the region on the capsid protein containing the mutation was involved in antibody binding, so the location of antigenic sites could be mapped precisely.
Other widely used techniques in these studies include binding of mono-and polyclonal antibodies to synthetic peptides representing parts of the primary sequence of capsid proteins, and the use of recombinant viruses engineered to display conformational epitopes. Table 1 shows the position of antigenic sites on members of the picornavirus family.
Poliovirus, human rhinovirus (HRV) and foot-andmouth disease virus (FMDV) are the most thoroughly mapped members of the family. HRV-14 and poliovirus are similar in that they have three major antigenic sites, labelled NIm-I, -II and -III on HRV-14 and site 1, 2, and 3 on poliovirus. These sites are highly variable and consist of exposed loops surrounding the "canyon' on the surface of the virion, which probably contains the receptor binding site (Rossmann, 1989) . The antigenic sites are in similar positions on the two viruses (see Fig.  2 ). NIm-I/site 1 is formed by loops on VP1 which compose a major protrusion at the fivefold axis. On HRV-14 this site consists of two independent sites which are a short distance apart on the surface of the virion, Stanway (1990) . HRV, human rhinovirus; PV, poliovirus: CAV, coxsackievirus A; CBV, coxsackievirus B; SVDV, swine vesicular disease virus; EV, enterovirus; BEV, bovine enterovirus; FMDV, foot-and-mouth disease virus; EMCV, encephalomyocarditis virus; TMEV, Theiler's murine encephalomyelitis virus; ECHO, echovirus; HAV, hepatitis A virus.
labelled NIm-IA and NIm-IB. Both VP1 and VP2 contribute to NIm-II/site 2, which includes the VP2 'puff' in the EF loop, which projects from the twofold axis of the capsid. Antigenic site 3 on poliovirus serotype 3 and NIm-II on HRV-14 are complex sites consisting of residues from VP3 and VP1. Site 3 on the other serotypes ofpoliovirus comprises the same region of VP3 but other residues are contributed by VP2. On poliovirus serotype 1, site 3 consists of two independent sites close together on the capsid-3A and site 3B (Page et al., 1988) . A prominent feature within poliovirus antigenic site 3 is the VP3 'knob', which is exposed at the threefold axis. In poliovirus serotypes 2 and 3, site 1 is immunodominant (Minor et al., 1985; Patel et al., 1993) , whereas sites 2 and 3 are dominant in serotype 1 (Page et al., 1988) .
Antibodies raised against the internal N terminus of VP 1 or the VP4 protein are capable of neutralizing virus infectivity (Li et al., 1994) . This is thought to occur as a (1991) . a, Amino acid sequence alignments for picornavirus proteins have been tabulated by Palmenberg (1989) . b, Data from Diamond et al. (1985) , Blondel et al. (1986 ), Page et al. (1988 and Weigers et al. (1989 Weigers et al. ( , 1990 . c, Data from Patel et al. (1993) . d, Data from Minor et al. (1985 ( ), Filman et al. (1989 and Hogle & Filman (1989) . e, Data from Rossman et al. (1985) and Sherry et al. (1986) . f, Data from Kitson et al, (1990) , based on the three-dimensional structure of serotype O1, elucidated by Acharya et al. (1989) . Neutralizing determinants have been correlated within structural elements for serotype O1 (Xie et al., 1987 ; Stave et al., 1988; Pfaff et al., 1989 : Barnett et al., 1989 Kitson et al., 1990) . Numbers in brackets correspond to the number of the antigenic site [i.e. (1) signifies the residues contribute to antigenic site 1]. g, Data from Ping et al. (1988) , Ping & Lemon (1992) and Nainan et al. (1992) . Correlated with structural features using the predicted structure of HAV (Luo et al., 1988) . h, Data from Boege et al. (199l) . Predicted sites (underlined) are from Muir et al. (1991) . i, Data from Zurbriggen & Fujinami (1989 ), Zurbriggen et al. (1991a , Ohara et al. (1988 ), Crane et al. (1990 ), Kim et al. (1992 and E. J. Usherwood and others (unpublished) . The three-dimensional structure has been elucidated for DA by Grant et al. (1992) , and BeAn by Luo et al. (1992) . j, Data from Huber et al. (1993) . k, Data from Reimann et al. (1991) . Abbreviations: FMDV, foot-and-mouth disease virus; HAV, hepatitis A virus; TMEV, Theiler's murine encephalomyelitis virus. (317, 145-153 and 337, 709-716) . result of reversible conformational changes at 37 °C which temporarily expose these regions for antibody binding. This illustrates that, despite our knowledge of the three-dimensional structures of many picornaviruses, they must be considered as dynamic entities rather than proteins in a fixed static configuration.
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FMDV differs markedly in surface design from poliovirus and HRV-I4 (Acharya et aL, I989) , yet the antigenic sites appear to be in similar regions to those described for HRV-14 and poliovirus. The 'FMDV loop', consisting of the GH loop of VP1 between residues 138 and 157, contains the major antigenic site. This loop is one of the most mobile regions on the virus surface, and consequently its structure could not be elucidated by X-ray crystallography of the native virion (Acharya et al., 1989) ; however, reduction of the disulphide bridges on the virion allowed the structure to be determined (Logan et al., 1993) . The C-terminal 13 residues of VP1 (200--213) are adjacent to this loop on the surface of the virion and also contribute to the antigenic site. Several groups have shown that FMDV has a total of at least four, or possibly five antigenic sites (Xie et al., 1987; Thomas et al., 1988; McCahon et al., 1989; Kitson et al., 1990; Crowther et al., 1993) , and their location varies with the virus serotype. In the O1 strain of FMDV site 2 consists of the BC and/?E-eB loops of VP2, which are located around the threefold axis of the virion, site 3 is the BC loop of VP1, at the fivefold axis, and site 4 is the 'knob' formed by an insert on fiB in VP3. Site 3 can be considered equivalent to site 1 on poliovirus, and site 1 (FMDV loop) is in the same region as residues involved in antigenic site 2. Sequences contributing to sites 2 and 4 can be considered a reassorted version of those involved in poliovirus antigenic sites 2 and 3 (Table 1) .
Hepatitis A virus (HAV) is difficult to grow in tissue culture, making the generation and characterization of variants more time-consuming. The virus has not yet been crystallized; however, Luo et al. (1988) predicted the structure by comparison with other picornaviruses. Competition experiments using monoclonal and polyclonal antibodies indicated that the virus possessed a single antigenic site which was dominant in mice and humans (Stapleton & Lemon, 1987) . Later work using monoclonal antibody-resistant variants (Ping et al., 1988; Ping & Lemon, 1992; Nainan et al., 1992) showed that VP3 residues 65, 70, 71 (VP3 'knob') and VP1 residues 102, 104 and 105 (BC loop) contributed to this immunodominant site, and VP1 residue 221 appeared to be involved in a second epitope. According to the predicted three-dimensional structure of HAV, the VP 1 and VP3 components of the immunodominant site are distant from one another (Nainan et al., 1992) , which is difficult to reconcile with the finding that they both contribute to the same antigenic site. It has been suggested that point mutations in the VP1 102-105 region may affect the VP3 site by changing the capsid conformation, rather than directly contributing to the antibody-binding domain (Nainan et al., 1992) .
Recent studies have begun to map the antigenic sites on Mengo virus. Point mutations conferring neutralization resistance were clustered in surface features arranged in a crescent around the threefold axis of the virion (Boege et al., 1991) . Residues frona the VP2 'puff' (144-148) and the VP3 'knob' (57 and 61) contributed to this site (Table 1) . A peptide with the C-terminal sequence of VP1 (259-277) induced neutralizing antibodies against Mengo virus in mice (Muir et al., 1991) . Immunization with this peptide increased the survival of mice infected with Mengo virus. Virus neutralization could not be inhibited by prior absorption of polyclonal anti-virus antibodies with the C-terminal peptide, however, casting doubt upon whether this region forms part of an antigenic site utilized during an immune response to the intact virus. Definition of the antigenic sites on Theiler's murine encephalomyelitis virus (TMEV) has been hindered by the lack of large panels of neutralizing monoclonal antibodies and neutralization-resistant variants. Two such variants have been characterized: one contained a point mutation in amino acid 101 of VP1, on the surfaceexposed loop II (Zurbriggen & Fujinami, 1989; Zurbriggen et al., 1991a) ; the other possessed a point mutation in amino acid 268 of VP1, which is in the exposed C terminus (Ohara et al., 1988) . Studies by B. S. Kim and colleagues (Crane et al., 1990; Kim et al., 1992) showed that several linear epitopes were present in capsid proteins VP1, VP2 and VP3. Polyclonal serum bound to fusion proteins containing VP1 amino acids 13-27, 145-167 and 251-276 (C terminus) and VP2 amino acids 2-14 and 165-179, in addition to VP3 amino acids 24-43. Antibody-binding studies using a panel of synthetic peptides covering the complete sequence of VP 1 showed that polyclonal anti-TMEV antibodies from infected mice bound to C-terminal peptides from VP1 (residues 225-276; E.J. Usherwood and others, unpublished) .
Based on the clustering of amino acid sequence differences between the GDVII and BeAn strains of TMEV, Pevear et al. (1988) predicted that antigenic sites may involve VP1 region 134-140, VP2 139-157, and possibly VP3 residues 57-63. When these are related to the three-dimensional structure of TMEV (Grant et aL, 1992; Luo et al., 1992) all are on the surface of the virion, one in the VP1 DE loop, another in the VP2 'puff' and the third in the VP3 'knob'. As mentioned above, the VP2 'puff' and VP3 'knob' form parts of the antigenic sites on poliovirus and Mengo virus.
All three external capsid proteins of coxsackievirus B3 contain epitopes recognized by polyclonal serum (Beatrice et al., 1980; Prabhakar, 1988; Auvinen et al., 1993) . Epitopes on VP1 were mapped using synthetic peptides, and they included the VP1 BC loop (Huber et al., 1993) . This loop also contains an epitope on the B4 serotype; the insertion of VP1 83-87 from B4 into the B3 serotype generated a virus which could be neutralized by serotype-specific antiserum raised against B4 (Reimann et al., 1991) .
Bovine enterovirus (BEV), which is endemic in cattle but causes an asymptomatic infection, has been the focus of studies by Smyth et al. (1990 Smyth et al. ( , 1992 . Peptides covering regions suspected of being antigenic sites were used to generate an antibody response, and peptide-specific antibodies were then screened to ascertain which were capable of neutralizing infectious BEV. The following peptides generated antibodies capable of precipitating and neutralizing infectious BEV: VP1 158-167, VPI 203-221, VP1 226-235, VP2 152-16l and VP3 54-63. The presence of epitopes on all three major capsid proteins was confirmed by the observation that polyclonal anti-BEV antibodies bound to VP 1, VP2 and VP3 on Western blots (Smyth et al., 1992) .
The antigenic sites on enterovirus-70 (EV-70), the causative agent of acute haemorrhagic conjunctivitis, have not yet been mapped. Radioimmunoprecipitation studies using monoclonal antibodies show that there is a conformational epitope involving all three external capsid proteins (Wiley et al., 1992) . VP1 is bound by monoclonal and convalescent human serum on western blots, suggesting the presence of a non-conformational epitope (Liu et al., 1988) .
T Cell epitopes on picornaviruses
Virus-specific cytotoxic T lymphocytes (CTL) have been recorded in experimental coxsackievirus B3 (Huber et al., 1980) and TMEV (Pena Rossi et al., 1991 : Lindsley et al., 1991 infections, after immunization of mice with poliovirus type 1 in adjuvant (Kutubuddin et al., 1992a) and in hepatitis A infection in humans (¥allbracht et aI., 1989) . Epitopes involved in this response have only been studied in the poliovirus system (Kutubuddin et al., 1992a) , where two peptides from VP1, amino acids 110-120 and 202 221, contained CTL epitopes recognized by BALB/C mice. Comparison with Table 1 shows that both of these epitopes are close to the regions in VP1 which form parts of antigenic site 1 on poliovirus type 1.
The production of neutralizing antibody in response to picornavirus infections requires the co-operation of B and T lymphocytes. Serum from mice experimentally infected with FMDV contained IgG of both T-independent (IgG3) and T-dependent (IgG1 and IgG2a) subclasses (Collen et al., 1989) . Primed B cells from these mice were unable to secrete virus-specific antibody in the absence of primed T cells or cytokines from T cell cultures. CD4 T cell recognition appears to be crossreactive between different serotypes of some picornaviruses [e.g. FMDV (Collen & Doel, 1990) , HRV (Hastings et al., 1993) and poliovirus (Katrak et al., 1991) ]. In addition, human T cell lines raised against one picornavirus cross-react with other picornaviruses, an exception being lines raised against EMCV (Graham et al., 1993) . This is interesting in light of the degree of sequence similarity between different members of the picornavirus family (reviewed in Stanway, 1990 ). To what extent this effect represents the conservation of T cell epitopes between different picornavirus genera remains to be seen, as T cell clones showed a more restricted cross-reactivity (Graham et al., 1993) .
CD4 T cell epitopes have been mapped most thoroughly in the poliovirus system (summarized in Table 2 ). Immunization of several strains of mice with live poliovirus type 1 resulted in a significant proliferative response against VP1 (Kutubuddin et al., 1992b ), but not VP2 or VP3. The epitopes within VP1 were mapped using synthetic peptides (see Table 2 ). Epitopes recognized by different mouse strains were scattered throughout VP1 ; however, peptides from the region VP1 202-241 could stimulate proliferative responses in all three strains tested. This region of VP1 contributes to antigenic site 2 (Table 1) .
Mahon et al. (1992) raised murine T cell clones from mice injected with live poliovirus and tested their specificity and cross-reactivity. Most clones which proliferated in response to all three poliovirus serotypes recognized VP4, and one cross-reactive clone recognized VP2. Serotype-specific clones, however, recognized either VP1 or VP3. VP4-specific clones responded to peptides from the region 6-35, which is highly conserved between the different poliovirus serotypes. Serotype-specific epitopes on VP3 were present in three regions- 14-28, 189-203 and 196-210 . The one VPl-specific clone responded to the 257-264 sequence. Three of these epitopes, were close to amino acids known to contribute to antigenic sites on polioviruses (VP1 residue 253 on serotype 3 and VP3 residue 207 on serotype 2 respectively). Another study reported the presence of a T cell epitope in the VPt BC loop, between amino acids 103-115, close to antigenic site 1 (Leclerc et al., 1991) .
The strains of poliovirus used in the studies described above do not establish a permissive infection in mice, so the epitopes selected may be different to those presented in the context of a productive infection. In contrast, studies in the human system concern T cell responses generated in response to either natural infection or vaccination with live, attenuated poliovirus. Simons et al. (1993) isolated peripheral blood lymphocytes from Sabin-vaccinated volunteers and found that they responded to isolated VP1, VP2 and VP3 proteins, in addition to synthetic VP4, suggesting the presence of T There is one report of the T cell epitope specificity in mice immunized with human rhinovirus (strain 1A, Hastings et al., 1993) . Three mouse strains were tested, all of which recognized a different pattern of epitopes (see Table 2 ). Areas containing clusters of epitopes were mostly present in internal parts of the capsid protein molecules, and therefore not associated with antigenic sites. Huber et al. (1993) showed that T cells from mice infected with coxsackie B3 virus proliferated in response to several peptides from VP1, including peptides representing the sequence of the BC loop and the C terminus (Table 2) .
T cell responses to hepatitis A virus are poorly characterized; however, there appears to be a T cell epitope in the C-terminal 156 amino acids of VP1 (Harmon et at., 1993) .
There is a CD4 T cell epitope between amino acids 33-47 of VP1 in the BeAn strain of TMEV (E.J. Usherwood and others, unpublished) , adjacent to a putative linear B cell epitope, VPI 13-27. One other T cell epitope has been reported on VP2, between residues 74-86 (Gerety et al., 1991 (Gerety et al., , 1994 . Recently synthetic peptides have been used to map T cell epitopes on the closely related Mengovirus. No epitopes were detected in VP1 or VP4; however, BALB/C and C57BL/6 mice recognized VP2 residues 118 132 and VP3 51-63 (Kobasa et al., 1993) . The VP2 epitope is located on an internal beta-sheet of the molecule, and the VP3 epitope in the surface-exposed VP3 'knob'.
A comparison of the location of T and B cell epitopes for the various picornaviruses shows that they are often close together on the primary protein sequence. This correlation is not absolute, and there are some T cell epitopes buried in the beta-sheet core of the capsid proteins. One interesting question arising from this observation is whether B cell epitopes determine the location of T cell epitopes or vice versa. Leclerc et al. (1991) immunized mice with an engineered poliovirus in which the VP1 94-102 linear B cell epitope was deleted to determine whether this would affect the presentation of the neighbouring T cell epitope in position 103-115. The mice still responded to the T cell epitope, suggesting antibody binding was not a prerequisite for presentation of the epitope. Molecular events involved in the reciprocal T-B relationship as regard epitope usage are not fully understood; however, one hypothesis is that following endocytosis of antibody-protein complexes the presence of the bound antibody influences peptide processing to favour the presentation of a neighbouring T cell determinant. An extension of this is that epitopespecific T cells may preferentially activate those B cells specific for a particular determinant on an antigen (Sercarz et al., 1993) .
Conclusions
From an immunological viewpoint the picornaviruses have been more thoroughly studied than any other virus family. Their small genome size has enabled complete sequences to be elucidated, and this knowledge has led to the widespread use of synthetic peptide technology and the construction of chimaeric viruses. Studies to date have focussed on antigenic sites located in the P1 region, and little evidence is available on immune responses to nonstructural proteins, although these proteins are certainly immuuogenic.
No effective peptide vaccine yet exists which can stimulate immunity to a range of virus serotypes in a mixed host population. Before such vaccines can be made 'promiscuous' B and T cell epitopes must be identified, so that protection can be achieved in an outbred population. Thus work such as that described above is essential if we are to combat picornavirusinduced disease by means of a new generation of safe, effective peptide vaccines. 
